|
Home
>
Newsletters
>
Washington Drug Letter
> Drugmakers Partner to Standardize GCP Training, Site Qualification
Washington Drug Letter
Oct. 1, 2012
| Vol.
44 No.
39
Drugmakers Partner to Standardize GCP Training, Site Qualification
Clinical trial sponsors could have an easier time qualifying trial sites and training investigators as a new Big Pharma initiative aims to standardize these procedures and support mutual recognition of qualification and training.
|
Related Articles
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.